Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
UTC Therapeutics Inc.
University of Virginia
Academic and Community Cancer Research United
Zhejiang Cancer Hospital
Instituto Ecuatoriano de Enfermedades Digestivas
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Delcath Systems Inc.
Khon Kaen University
Ajou University School of Medicine
McGill University Health Centre/Research Institute of the McGill University Health Centre
Curegenix Inc.
RenJi Hospital
Shanghai Golden Leaf MedTec Co. Ltd
University of Cape Town
Johann Wolfgang Goethe University Hospital
Weill Medical College of Cornell University
The First Affiliated Hospital of Xiamen University
Seoul National University Hospital
National Cancer Institute (NCI)
Chiba University
National Cancer Institute (NCI)
Simcere Pharmaceutical Co., Ltd
Wakayama Medical University
National Cancer Institute (NCI)
Yonsei University
Charite University, Berlin, Germany